SCHEMBL8340917

SCHEMBL8340917

CN1CCc2ccc(-n3ccncc3=O)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.41
CYP1A2 P05177 2/20 0.39
TSHR P16473 2/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39
RAB9A P51151 1/20 0.39
HIF1A Q16665 1/20 0.39
MAPT P10636 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
AR P10275 1/20 0.38
MAPK14 Q16539 1/20 0.37
CYP17A1 P05093 2/20 0.34
CYP11B1 P15538 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340084 0.89 CYP1A2 (0.46) NOTUMCYP1A2TSHRNPC1TP53
SCHEMBL8340891 0.79 HRH4 (0.41) NOTUMTSHRPKMARF10
SCHEMBL26683787 0.75 CRBN (0.45) NOTUMTSHRMAPTARDRD2
SCHEMBL16720167 0.70 MAPT (0.40) NOTUMCYP1A2NPC1CYP2D6RAB9A
SCHEMBL5625864 0.69 CYP11B2 (0.41) CYP11B1CYP11B2BRD4
SCHEMBL5626795 0.69 CYP11B2 (0.45) CYP1A2MAPTARCYP11B1CYP11B2
SCHEMBL26683782 0.69 CRBN (0.56) NOTUMTSHRCRBNALOX15BRCA1
SCHEMBL256336 0.69 HTR2A (0.43) NOTUMCYP1A2TSHRNPC1TP53
SCHEMBL8340201 0.69 NOTUM (0.42) NOTUMARHTR1AF10DRD2
SCHEMBL5626038 0.68 CYP11B2 (0.44) TSHRTP53CYP11B1CYP11B2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070129361-A1 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS QIAO JENNIFER X 2007-06-07 US disclosed
US-20070129361-A1 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS QIAO JENNIFER X 2007-06-07 US disclosed
WO-2004031145-A2 LACTAM-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129361-A1 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS PEPD, XPNPEP1, METAP1 NOTUM 486/4885CYP1A2 2248/4885TSHR 3524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.